Latest IMI Intelligent Medical Implants GmbH Stories
BONN, Germany, April 6 /PRNewswire/ -- IMI Intelligent Medical Implants, a pioneer developer of a system designed to restore vision to people blinded by diseases such as retinitis pigmentosa or macular degeneration, has named veteran life sciences executive, Robert J. Rosenthal, Ph.D., chief executive officer. He is also a member of the IMI board of directors. Dr. Rosenthal has more than 20 years of experience fostering product innovation and building value for customers, shareholders, and...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.